Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts

This study provides the first indication of a novel dual therapy approach for the potential treatment of SMA. Graphical abstract
Source: Neurochemistry International - Category: Neuroscience Source Type: research